Vanguard Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$163M Buy
11,916,620
+6,755
+0.1% +$92.1K ﹤0.01% 1230
2026
Q2
$161M Buy
11,909,865
+172,847
+1% +$2.07M ﹤0.01% 1277
2026
Q1
$70.3M Buy
+11,737,018
New +$88.3M ﹤0.01% 1667

Other funds holding OGN

Vanguard Capital Management's OGN Position: Q3 2026 in Review

Vanguard Capital Management increased its Organon & Co (OGN) stake by 0.06% in Q3 2026, buying an estimated $92.1K and bringing the position to 11,916,620 shares worth $163M. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

Vanguard Capital Management first reported a position in OGN in Q1 2026 and has held it in 3 quarters since. 604 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Vanguard Capital Management held 11,916,620 shares of Organon & Co worth $163M as of Q3 2026.
  • Vanguard Capital Management bought 6,755 Organon & Co shares in Q3 2026, an estimated $92.1K.
  • Organon & Co made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1230 holding.
  • Vanguard Capital Management first reported a position in Organon & Co in Q1 2026 and has held it in 3 quarters since.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.